Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19)...

added blog Health

2023-08-04 14:35:16 -

Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Predicted to Witness Surge in The Near Future

The human immunoglobulin (pH4) for intravenous injection market is expected to witness a surge in the near future. This is primarily attributed to the ongoing COVID-19 pandemic, which has led to an increased demand for potential therapeutic options. Human immunoglobulin (pH4) is being explored as a treatment option for severe COVID-19 cases due to its ability to boost the immune response...

0 Comments 0 Shares 2K Views 0 Reviews